Immunic
IMUX
IMUX
62 hedge funds and large institutions have $92.4M invested in Immunic in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.18% more ownership
Funds ownership: 61.97% → 62.16% (+0.18%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $118K | Put options by funds: $698K
Holders
62
Holding in Top 10
1
Calls
$118K
Puts
$698K
Top Buyers
| 1 | +$3.54M | |
| 2 | +$1.58M | |
| 3 | +$855K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$704K |
| 5 |
Morgan Stanley
New York
|
+$603K |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$1.05M | |
| 3 | -$368K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$321K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$138K |